期刊文献+

补骨脂酚经蛋白激酶Cε拮抗内皮细胞缺血再灌注损伤 被引量:2

Bakuchiol protects vascular endothelial cells against ischemia reperfusion injury via PKCε signaling pathway
下载PDF
导出
摘要 目的研究补骨脂酚(BAK)对血管内皮细胞模拟缺血再灌注损伤(SIR)的保护作用及其分子机制。方法用不同浓度BAK(2,5,10μmol/L)预处理体外培养的人脐静脉内皮细胞(HUVECs)24 h,接受模拟缺血再灌注(SIR)损伤(缺血45min,再灌注4 h),用CCK-8法和TUNEL法分别检测细胞活力和凋亡率,酶活性测定法检测培养液中乳酸脱氢酶(LDH)活性,细胞中丙二醛(MDA)的含量及超氧化物歧化酶(SOD)的活性,DHE荧光探针检测细胞中活性氧(ROS)的含量,Western blot法检测细胞膜PKCε、细胞质PKCε、Bcl-2、Bax、cleaved caspase 3和gp91phox蛋白的表达水平。使用PKCε特异性阻断剂εV1-2阻断该信号通路,进一步探究PKCε信号通路在其中的作用。结果 BAK预处理呈剂量依赖性地改善内皮细胞SIR损伤,且10μmol/L剂量效果最佳。BAK预处理可明显提高缺血再灌注损伤后内皮细胞活力,减少LDH释放,增强细胞中SOD活性,降低MDA含量及gp91phox蛋白表达量,减少ROS的产生;促进抗凋亡蛋白Bcl-2的表达,抑制凋亡蛋白cleaved caspase 3,Bax的表达,降低再灌注损伤后细胞凋亡率;并且显著促进PKCε膜转位,而特异性阻断PKCε信号通路可逆转BAK的上述保护作用(均P<0.05)。结论 BAK通过激活PKCε信号通路,进而增强细胞抗氧化应激和抗凋亡能力,最终缓解内皮细胞缺血再灌注损伤。 Objective To explore the protective effects of bakuchiol( BAK) against simulated ischemia reperfusion( SIR)-induced injury in human umbilical vein endothelial cells( HUVECs) and its underlying mechanisms. Methods The cultured HUVECs were pretreated with BAK(2,5,10 μmol/L) for 24 h and then subjected to SIR(45 min ischemia,4 h reperfusion). Cell viability and apoptotic index were detected by CCK-8 and TUNEL methods,and the lactate dehydrogenase( LDH) releasing,intracellular malondialdehyde( MDA) content,superoxide dismutase( SOD) were all assessed by specialized kits. The translocation of protein kinase C epsilon(PKCε) and the expression levels of Bcl-2,Bax,cleaved caspase 3 and oxidative stress marker gp91 phoxwere detected by Western blot. Dihydroethidium( DHE),a fluorescence probe,was used to detect the presence of reactive oxygen species( ROS). The εV1-2,a specific inhibitor of PKCε signaling,was used to further study the role of PKCε in this process. Results BAK pretreatment protected HUVECs against SIR injury in a dose-dependent manner,especially at the concentration of 10 μmol/L. BAK pretreatment significantly improved the cell viability,reduced LDH releasing,up-regulated the SOD activity and down-regulated the MDA content of SIR-treated HUVECs( P 〈 0. 05). In addition,BAK supplementation significantly reduced the apoptotic index,increased PKCε translocation and Bcl-2 expression,and decreased the expression levels of cleaved caspase 3,Bax and gp91 phox( P 〈 0. 05). However,the protective effects of BAK mentioned above were significantly attenuated by εV1-2( P 〈 0. 05). Conclusion BAK pretreatment can protect against SIR-induced oxidative stress and apoptosis on HUVECs via PKCε signaling pathway.
出处 《山西医科大学学报》 CAS 2017年第10期975-981,共7页 Journal of Shanxi Medical University
基金 北京市自然科学基金资助项目(7122178) 总参军事医学和老年病科研基金资助项目(ZCWS14C12)
关键词 补骨脂酚 人脐静脉内皮细胞 缺血再灌注损伤 蛋白激酶C EPSILON 氧化应激 凋亡 bakuchiol human umbilical vein endothelial cells ischemia reperfusion injury protein kinase C epsilon oxidative stress apoptosis
  • 相关文献

参考文献2

二级参考文献14

  • 1赵志青,臧益民.再灌注心脏保护的新策略:后处理和预处理的比较(英文)[J].心脏杂志,2006,18(1):1-7. 被引量:31
  • 2Kwon H S, Ott M. The ups and downs of SIRT1 [ J]. Trends Bio-chem Sci, 2008, 33(11) :517-525. 被引量:1
  • 3Yu J, Wei J, Ji L, et al. Exploration on mechanism of a new typeof melatonin receptor agonist Neu-pl 1 in hypoxia - reoxygenationinjury of myocardial cells [ J ] . Cell Biochem Biophys, 2014, 70(2):999-1003. 被引量:1
  • 4Sengupta A, Molkentin JD, Yutzey KE. FoxO transcription factorspromote autophagy in cardiomyocytes [ J]. J Biol Chem, 2009,284(41) :28319-28331. 被引量:1
  • 5Zheng X, Lian D, Wong A., et al. Novel small interfering RNA-containing solution protecting donor organs in heart transplantation[J]. Circulation, 2009,120(12) : 1099-1107. 被引量:1
  • 6Smith CC,Mocanu MM,Davidson SM, et al. Leptin,the obesity-associated hormone,exhibits direct cardioprotective effects[ J].BrJ Pharmacol, 2006,149(1) :5-13. 被引量:1
  • 7Dubocovich ML, Masana MI,Iacob S, et al. Melatonin receptorantagonists that differentiate between the human Mel la and Mel lbrecombinant subtypes are used to assess the pharmacological pro-file of the rabbit retina ML1 presynaptic heteroreceptor [ J ]. Nau-nyn Schmiedebergs Arch Pharmacol, 1997,355(3) :365-375. 被引量:1
  • 8Reiter RJ,Tan DX,Gitto E, e/ a/ . Pharmacological utility of me-latonin in reducing oxidative cellular and molecular damage [ J ].Pol J Pharmacol, 2004,56(2) : 159-170. 被引量:1
  • 9Karbownik M,Reiter RJ. Antioxidative effects of melatonin inprotection against cellular damage caused by ionizing radiation[J]. Proc Soc Exp Biol Med, 2000, 225(1) :9-22. 被引量:1
  • 10Lochner A,Genade S, Davids A, et al. Short - and long - termeffects of melatonin on myocardial post-ischemic recovery [ J ]. JPineal Res, 2006, 40(1) :56-63. 被引量:1

共引文献19

同被引文献24

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部